SalaryGuide
AboutPricingFor Employers

Marketing jobs

1 marketing jobs

UT MD Anderson logo
4 months ago

Communications Program Manager - Public Relations

UT MD Anderson

Houston, TX (Remote)Full time$93K/yr – $139K/yr

All marketing roles in the US with a remote work arrangement

Get alerts for this search

All marketing roles in the US with a remote work arrangement

Get alerts for this search

1 jobs
UT MD Anderson logo

Communications Program Manager - Public Relations

UT MD Anderson

Houston, TX (Remote)

$93K/yr - $139K/yrIn-houseFull-timeSenior level6+ years exp.
4 months ago
UT MD Anderson logo
UT MD Anderson

Communications Program Manager - Public Relations

Houston, TX (Remote)

$93K/yr – $139K/yrSenior Level6+ years expFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive scientific communications for basic and translational research programs as a Communications Program Manager at MD Anderson, partnering with leadership to shape media strategy and measure impact.

  • Own and develop communication strategies for research programs and industry collaborations.
  • Track and analyze PR work to guide decisions and evaluate effectiveness.
  • Partner with the Program Director and leadership to deliver metrics reports to stakeholders.

Job Description

Drive scientific communications for basic and translational research programs as a Communications Program Manager at MD Anderson, partnering with leadership to shape media strategy and measure impact.

  • Own and develop communication strategies for research programs and industry collaborations.
  • Track and analyze PR work to guide decisions and evaluate effectiveness.
  • Partner with the Program Director and leadership to deliver metrics reports to stakeholders.
UT MD Anderson logo

UT MD Anderson

4.1 Glassdoor

The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson provides cancer care at several convenient locations throughout the Greater Houston Area and collaborates with community hospitals and health systems nationwide through MD Anderson Cancer Network®.U.S. News & World Report's "Best Hospitals" survey has ranked MD Anderson the nation's top hospital for cancer care. Every year since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals. The recognition reflects the passion of our 21,000 extraordinary employees and 1,000 volunteers for providing exceptional care to our patients and their families, and for realizing our mission to #EndCancer. You can view all of our career opportunities at careers.mdanderson.org.

Founded in 1944
Houston, Texas, USA
23K employees (314 in marketing)
MDAnderson.org
83% recommend to a friend
89% CEO approval

Traffic Signals

Monthly Visitors
3M
Monthly Google Ads Budget
$849.4K
Traffic Source Mix
Search
54.1%
Direct
38.2%
Referral
5.8%
Social
1.2%
Paid
0.6%

Headcount Trend

Current headcount: ~22.6K

Marketing Team

Marketing Team Size
196 (1% of company)
Median Career Experience
14 years
Median Tenure
6.9 years
Marketing Roles Posted (Last 30 Days)
1

People

Marketing Leadership

Dana Hoyland Lee
Dana Hoyland Lee
Associate Vice President, Marketing
At the company for 16 years 7 months
Mahogany M. Johnson
Mahogany M. Johnson
Program Marketing Director
At the company for 1 year 10 months
Katelyn Engelking
Katelyn Engelking
Director, Marketing Analytics
At the company for 1 year 10 months
Stephanie Carrell
Stephanie Carrell
Marketing Director
At the company for 13 years 1 month

Funding

Total Funding
$16.2M
Last Raise
$2.7M
Grant, 3 years ago

Funding History

  • May 2023
    Grant • $2.7M
  • Jan 2023
    Grant • $3.5M
  • Apr 2022
    Grant • $10M

Recent News

At 10 years, stereotactic body radiation therapy comparable to surgery for early-stage lung cancer
Sep 26, 2025 • Medical Xpress - latest medical and health news stories
Study offers rare insight into experiences of children raised by cardiothoracic surgeons
Sep 23, 2025 • News-Medical.Net
MD Anderson Board of Visitors welcomes new members, honors new Life Member
Sep 18, 2025 • MD Anderson Cancer Center
Glucose-fructose mix found in sugary drinks fuels colorectal cancer metastasis
Sep 18, 2025 • News-Medical.Net
Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research
Sep 17, 2025 • Ernexa Therapeutics Inc.
Opinion: To Scale Cell Therapy, Regional Manufacturing Is the Smart Middle Path
Sep 16, 2025 • BioSpace
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-250 for Myeloid Malignancies
Sep 16, 2025 • PharmiWeb
Mann Eye Institute Welcomes Internationally Renowned Ophthalmic Oncology Expert Dr. Bita Esmaeli
Sep 15, 2025 • PR Newswire
Nemours recruits new division chief from MD Anderson Cancer Center
Sep 12, 2025 • Seattle TechFlash
Journal of Neuro-Oncology Publishes New Data Reinforcing GammaTile® Efficacy in Treating Recurrent Brain Metastases
Sep 11, 2025 • PR Newswire
Banner Health hires new neurosurgeon for Greeley hospital
Sep 11, 2025 • BizWest
CERo Therapeutics Announces Dose Intensification in Phase 1 Study of CER-1236 in Acute Myeloid Leukemia
Sep 8, 2025 • Morningstar.com
Can live music actually heal the body? MD Anderson doctors test the idea
Sep 7, 2025 • KHOU
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Sep 5, 2025 • MD Anderson Cancer Center
MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies
Sep 5, 2025 • EIN Presswire
Ori's cell and gene platform wins key FDA advanced manufacturing designation
Sep 3, 2025 • FiercePharma
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors
Sep 2, 2025 • Morningstar.com
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors
Sep 2, 2025 • BioSpace
A keto diet might benefit females more than males, a new UT Health San Antonio study suggests
Aug 28, 2025 • PR Newswire
Radiopharma CDMO Nucleus names former FDA boss as CEO
Aug 25, 2025 • pharmaphorum
Nucleus RadioPharma names former FDA Commissioner as CEO
Aug 22, 2025 • Pharma Letter
CRISPR screening identifies key targets to strengthen CAR NK cell therapies
Aug 21, 2025 • Medical Xpress - latest medical and health news stories
New genome-wide CRISPR screening tool boosts natural killer cells to fight cancer
Aug 21, 2025 • News-Medical.Net
MD Anderson awards top honors to exceptional faculty
Aug 15, 2025 • MD Anderson Cancer Center
A fraudulent cancer breakthrough, a test for the future president of MIT, and a new age of doubt in science
Aug 13, 2025 • Boston Globe
Blocking brain-liver communication may prevent deadly weight loss in cancer
Aug 7, 2025 • Medical Xpress - latest medical and health news stories
First Patient Treated in New Study Investigating Graft-Versus-Host-Disease (GVHD) Prevention Strategies for Mismatched Unrelated Donor Hematopoietic Cell Transplants
Aug 6, 2025 • Business Wire
Global RNA Polymerase I Clinical Trials: Opportunities and Insights Report 2025
Aug 5, 2025 • Research and Markets
Stem Cell Therapy Market Size to Lead USD 54.45 Billion by 2034 Driven by Advancements in Regenerative Medicine and Personalized Treatments
Jul 31, 2025 • BioSpace
Global Multiple Myeloma Therapeutics Market and Forecast to 2030
Jul 31, 2025 • PR.com
MD Anderson, Toppan Holdings Team up to Develop Organoid Assay for Personalized Cancer Treatment
Jul 30, 2025 • GenomeWeb
MD Anderson and TOPPAN Holdings to co-develop organoid technology
Jul 29, 2025 • MD Anderson Cancer Center
Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update
Jul 29, 2025 • Radiopharm Theranostics
MD Anderson ranked No. 1 in the nation for cancer care
Jul 28, 2025 • MD Anderson Cancer Center
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Jul 28, 2025 • Radiopharm Theranostics
Structured 'bridge' protein links disordered gene regulators to control gene expression
Jul 21, 2025 • PhysOrg.com
$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical
Jul 18, 2025 • Research and Markets
Texas Health Market Review 2025 - ResearchAndMarkets.com
Jul 18, 2025 • Business Wire
KCCC, IAEA host workshop on advanced radiation therapy for gynecological tumors
Jul 13, 2025 • News Archives - Times Kuwait
Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy
Jul 11, 2025 • News-Medical.Net
Most patients with advanced melanoma remain disease-free 4 years after pre-surgical immunotherapy, study finds
Jul 10, 2025 • Medical Xpress - latest medical and health news stories
Rare kidney cancer evades immune system in unique ways
Jul 3, 2025 • News-Medical.Net
New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
Jul 2, 2025 • Medical Xpress - latest medical and health news stories
MD Anderson achieves sixth Magnet designation in recognition of nursing excellence
Jun 24, 2025 • MD Anderson Cancer Center
UTA receives grant to tackle low physical activity among cancer survivors
Jun 18, 2025 • News-Medical.Net
For the first time, scientists grow beating human-pig hearts for 21 days
Jun 17, 2025 • Research & Development World
Former MD Anderson researcher unveils tech to 'democratize' access to cancer research
Jun 12, 2025 • Seattle TechFlash
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
Jun 10, 2025 • MarketScreener
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
Jun 10, 2025 • BioSpace
MD Anderson and HealthEx announce collaboration to develop new platform to give patients direct control of data access
Jun 9, 2025 • MD Anderson Cancer Center
Mailed self-collection HPV tests more than double cervical cancer screening rates, study shows
Jun 6, 2025 • Medical Xpress - latest medical and health news stories
IBC Bank raises over $4 million for MD Anderson
Jun 4, 2025 • MD Anderson Cancer Center
Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer
Jun 2, 2025 • Medical Xpress - latest medical and health news stories
Pre-surgical combination therapy boosts survival in patients with rare thyroid cancer
Jun 2, 2025 • Medical Xpress - latest medical and health news stories
MD Anderson-affiliated Cancer Focus Fund seeks $250 million in new funding for biotech investments
Jun 1, 2025 • Seattle TechFlash
Most Americans unaware of cancer risks associated with drinking alcohol, study finds
May 29, 2025 • Medical Xpress - latest medical and health news stories
Single-cell RNA sequencing of bone metastases from multiple cancer types reveals three distinct immune archetypes
May 23, 2025 • Medical Xpress - latest medical and health news stories
ASCO: MD Anderson researchers present high-impact studies across multiple cancers
May 22, 2025 • MD Anderson Cancer Center
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
May 22, 2025 • Press Telegram
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
May 22, 2025 • Livemint.com
CPRIT awards over $21 million to MD Anderson for cancer research and faculty recruitment
May 21, 2025 • MD Anderson Cancer Center
Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
May 15, 2025 • BioSpace
Texas Children’s Hospital and UT MD Anderson Announce $150 Million Gift from Kinder Foundation to Launch Kinder Children’s Cancer Center
May 14, 2025 • Texas Children’s
Texas Children's Hospital and UT MD Anderson Announce $150 Million Gift from Kinder Foundation to Launch Kinder Children's Cancer Center
May 14, 2025 • PR Newswire
MD Anderson, Texas Children's to build Kinder Children's Cancer Care hospital with $150 million gift
May 14, 2025 • Seattle TechFlash
What is AI really giving back to tech investors? Here's the hard truth.
May 14, 2025 • Morningstar.com
Texas Children's Hospital and UT MD Anderson Announce $150 Million Gift from Kinder Foundation to Launch Kinder Children's Cancer Center
May 14, 2025 • Morningstar.com
All roads led to MD Anderson for nursing institute head
May 6, 2025 • MD Anderson Cancer Center
MD Anderson tops $2.5 million at A Conversation With a Living Legend® Washington, D.C., honoring Ken Burns
May 4, 2025 • MD Anderson Cancer Center
ImmunoGenesis Expands Phase 1a/b Trial of IMGS-001 for Advanced Solid Tumors to Ochsner MD Anderson Cancer Center
May 1, 2025 • Cancer Focus Fund
Small Biopsies, Big Insights: How Tiny Tissue Samples Could Transform Glioblastoma Research
Apr 30, 2025 • EIN Presswire
AACR: Researchers share promising results from MD Anderson clinical trials
Apr 25, 2025 • MD Anderson Cancer Center
Triple-negative breast cancer survivor: Why I chose a clinical trial at MD Anderson
Apr 23, 2025 • MD Anderson Cancer Center
AACR: MD Anderson researchers share cancer breakthroughs
Apr 22, 2025 • MD Anderson Cancer Center
Revolutionary Tumor-Fighting Cell Therapy: MD Anderson to Present Ernexa's Ovarian Cancer Breakthrough at AACR
Apr 22, 2025 • Stock Titan
CERo Therapeutics Lands $8M Series D Funding: FDA-Cleared Cancer Trials at MD Anderson Set to Launch
Apr 22, 2025 • Stock Titan
AACR: Five MD Anderson researchers honored with 2025 Scientific Achievement Awards
Apr 21, 2025 • MD Anderson Cancer Center
Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
Apr 21, 2025 • Morningstar.com
Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
Apr 21, 2025 • GlobeNewswire
Compass Therapeutics (CMPX) Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
Apr 21, 2025 • StreetInsider.com
AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy
Apr 18, 2025 • MD Anderson Cancer Center
MD Anderson Research Highlights for April 17, 2025 | Newswise
Apr 17, 2025 • Newswise
Head of Cancer Medicine: ‘MD Anderson is the place I bring my loved ones’
Apr 15, 2025 • MD Anderson Cancer Center
Emirati leads charge to reduce cost of one of world's most expensive cancer treatments
Apr 12, 2025 • The National
Gynecologic oncologist: Why I’m passionate about cancer care at MD Anderson
Apr 10, 2025 • MD Anderson Cancer Center
MD Anderson Cancer Center president says more suburbs under consideration for future expansion
Apr 3, 2025 • Seattle TechFlash
MD Anderson breaks ground on new Sugar Land location
Mar 31, 2025 • MD Anderson Cancer Center
Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial
Mar 31, 2025 • Aprea Therapeutics
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
Mar 31, 2025 • MedCity News
Texas Children’s Hospital and UT MD Anderson Cancer Center join forces to end pediatric cancer
Mar 27, 2025 • American Hospital Association
Global Paranasal Sinus Cancer Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
Mar 27, 2025 • EIN Presswire
MD Anderson names Jeffrey E. Lee, M.D., Chief Medical Executive
Mar 26, 2025 • MD Anderson Cancer Center
Blood test for ovarian cancer misses some Black and Native American patients, study finds
Mar 21, 2025 • Press Telegram
Texas Health Market Review 2025: Hospitals & HMOs Navigate Profitability Amid Medicaid Cuts
Mar 20, 2025 • GlobeNewswire News Room
Blood test for ovarian cancer misses some Black and Native American patients, study finds
Mar 20, 2025 • AP News
Why I began my nursing career at MD Anderson
Mar 18, 2025 • MD Anderson Cancer Center
MD Anderson to explore Aprea’s WEE1 kinase inhibitor for HNSCC
Mar 12, 2025 • BioWorld Financial Watch
MD Anderson raises $1.8 million at A Conversation With a Living Legend® event honoring Taylor Sheridan
Mar 11, 2025 • MD Anderson Cancer Center
Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)
Mar 11, 2025 • BioSpace
Stage IV oral cancer survivor: How MD Anderson helped me reclaim my faith
Mar 6, 2025 • MD Anderson Cancer Center